Dr. Michael Ethan Carney, MD

Dr. Carney practices at Kapiʻolani Medical Center for Women & Children in Honolulu, Hawaii, part of Hawaiʻi Pacific Health.

Dr. Carney's NPI, 1790893287, was assigned on August 26, 2006. Dr. Carney graduated from Loyola University Chicago Stritch School of Medicine in 1990. Dr. Carney holds Hawaii license MD-11601.

Dr. Carney's primary practice is Kapiʻolani Medical Center for Women & Children, at 1319 Punahou Street, Honolulu, HI 96826 in Honolulu County. The practice phone is (808) 983-6000.

Dr. Carney's primary practice is Kapiʻolani Medical Center for Women & Children in Honolulu, Hawaii, part of Hawaiʻi Pacific Health. Dr. Carney is also affiliated with The Queen's Medical Center. The medical group on file is Hawaii Pacific Health Medical Group. Dmand AI also links Dr. Carney to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carney practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Carney's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Carney is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Carney's licenses on file in 3 states: Hawaii, Utah and North Carolina.

Dmand AI lists hysterectomy and ovarian cyst among the conditions Dr. Carney treats.

CMS data shows 306 Medicare services from Dr. Carney across 7 procedure codes in 2024, for 138 Medicare patients. Medicare paid $48,448 for them.

CMS counts 138 Medicare patients who saw Dr. Carney in 2024. The largest group is 65 to 74, with 64 patients. 75% of them have high cholesterol, and 64% have high blood pressure. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Carney's median patient age at 66, with 99% women.

In 2024, Dr. Carney wrote 203 Medicare Part D claims for 56 patients. 92% of them were for generic drugs. CMS names the drug for 130 of them, across 7 drugs with 11 or more claims each, at $1,745 in total drug cost. In 2023, CMS named 78 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Carney for performance year 2024, reported as part of a group. Dr. Carney accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 36 procedures of removal of the uterus by Dr. Carney, more than 98% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 87 papers to Dr. Carney, published from 2005 to 2025. 2019 was the busiest year, with 4. The most frequent topics are Ovarian Neoplasms, Genetic Predisposition to Disease and Polymorphism, Single Nucleotide. Dr. Carney has published most often in Cancer Epidemiol Biomarkers Prev. Dr. Carney's most frequent co-authors are Beth Y. Karlan, MD, Michael E. Jones, MD and Rebecca Sutphen, MD.

Dmand AI links Dr. Carney to 16 clinical trials, 10 of them phase 3 studies. 9 are still active or recruiting. Conditions studied include Fallopian Tube Diseases, Fallopian Tube Neoplasms and Carcinosarcoma. National Cancer Institute (NCI) sponsors the most, 8.

CMS Open Payments shows 25 general payments to Dr. Carney from 12 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 67% of the total. Intuitive Surgical, Inc. paid the most, $1,421.

Dmand AI lists 2 awards for Dr. Carney.

Dr. Carney graduated from Loyola University Chicago Stritch School of Medicine in 1990. Dr. Carney is a member of AOA, American College of Obstetricians and Gynecologists, ASCO, Hawaii Society of Clinical Oncology, ICGS and SGO.

Dr. Carney is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.